Search for Reversing Agents of Multidrug-Resistance in Tumor Cells from Marine Organisms

从海洋生物中寻找肿瘤细胞多药耐药性逆转剂

基本信息

  • 批准号:
    10680567
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 1999
  • 项目状态:
    已结题

项目摘要

In the course of our study of bioactive substances from marine organisms, we focused on a search for reversing agents of multidrug resistance (MDR) in tumor cells. We used two kinds of MDR human epidermoid carcinoma cell lines, KB-C2 cells overexpressing P-glycoprotein (P-gp) and KB-CV60 cells overexpressing multidrug resistance associated protein (MRP) for the screening assay. We found that araguspongines conquered MDR in KB-C2 cells. Araguspongines were isolated from an Okinawan marine sponge of Xestospongia sp. and characterized as macrocyclic dimer of 2,9-disubstituted 1-oxaquinolizidine. Araguspongine D, which is a major component among araguspongines, completely conquered MDR in KB-C2 cells at 10 μg/ml. Araguspongines B and E, which were stereoisomers of araguspongine D, also completely reversed MDR in KB-C2 cells. 5,5'-N-Dimethyl derivative and 2,2'-diol synthesized from araguspongine E did not show reversing activity. We isolated cembrane-type diterpenes reversing MDR in KB-C2 cells from a soft coral of Sinularia sp. This cembranoid completely conquered MDR in KB-C2 cells at 10 μg/ml. This cembranoid is seemed to be an artifact compound, which was produced from known natural cembranolide by addition of n-BuOH. We synthesized a series of cembrane derivatives replaced the n-butyl ester with various alcohols and found that the reversing activity of those derivatives were related to the carbon number of alcohol. Agosterol A, a novel polyhydroxylated sterol acetate, was isolated from a marine sponge of Spongia sp. as a reversing agent of MDR. Agosterol A perfectly reversed resistance to colchitine in KB-C2 cells and resistance to vincristine in KB-CV60 cells at 3μM concentration. Agosterol A recovered the accumulation of vincristine in KB-C2 and KB-CV60 cells to the level equal to that of parental KB 3-1 cells at 3 μM concentration.
在海洋生物活性物质的研究过程中,我们的重点是寻找肿瘤细胞中多药耐药(MDR)的逆转剂。我们使用过表达p -糖蛋白(P-gp)的KB-C2细胞和过表达多药耐药相关蛋白(MRP)的KB-CV60细胞两种MDR人表皮样癌细胞进行筛选。我们发现,在KB-C2细胞中,蜘蛛碱能够攻克耐多药耐药。从日本冲绳海绵中分离得到一种巨环2,9-二取代- 1-草喹喹啉二聚体。在10 μg/ml的浓度下,阿拉木皂素D完全攻克了KB-C2细胞的MDR。槟榔素B和E是槟榔素D的立体异构体,也能完全逆转KB-C2细胞的MDR。由木棉素E合成的5,5′- n -二甲基衍生物和2,2′-二醇不具有逆转活性。我们从Sinularia sp.软珊瑚中分离出逆转KB-C2细胞MDR的膜型二萜,这种膜类物质在10 μg/ml浓度下完全克服了KB-C2细胞的MDR。这种类胶质物质似乎是一种人造化合物,它是由已知的天然胶质内酯通过添加n-BuOH而产生的。我们合成了一系列用不同醇取代正丁基酯的膜衍生物,发现这些衍生物的逆转活性与醇的碳数有关。从海绵中分离出一种新型的多羟基化醋酸甾醇A作为耐多药的逆转剂。Agosterol A在3μM浓度下完全逆转了KB-C2细胞对秋几丁碱的抗性和KB-CV60细胞对长春新碱的抗性。Agosterol A使KB- c2和KB- cv60细胞长春新碱的积累恢复到3 μM浓度下与亲本KB- 3-1细胞相当的水平。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
N. Murakami: "Total synthesis of callystatin A, a potent cytotoxic polyketide from the marine sponge, Callyspongia truncata"Tetrahedron Lett.. 39. 23498-2352 (1998)
N. Murakami:“callystatin A 的全合成,一种来自海洋海绵 Callyspongia truncata 的有效细胞毒性聚酮化合物”Tetrahedron Lett.. 39. 23498-2352 (1998)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S.Aoki: "Agostereol A, a novel polyhydroxylated sterol acetate reversing multidrug resistance from a marine sponge of spongia sp"Tetrahedron Letter. 39. 6303-6306 (1998)
S.Aoki:“Agostereol A,一种新型多羟基化甾醇乙酸酯,可逆转海绵的多药耐药性”四面体信件。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S.Aoki: "Agosterol A, a novel polyhydroxylated sterol acetate rerersing multidrug resistance from marine sponge of spongia SP" Tetrahedron Lett. 39. 6303-6306 (1998)
S.Aoki:“Agosterol A,一种新型多羟基化甾醇乙酸酯,可逆转海绵 SP 的多药耐药性”四面体 Lett。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KOBAYASHI Motomasa其他文献

KOBAYASHI Motomasa的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KOBAYASHI Motomasa', 18)}}的其他基金

Creation of novel molecular-targeted anticancer drugs focused on specific phenotypic changes of cells in tumor
开发专注于肿瘤细胞特定表型变化的新型分子靶向抗癌药物
  • 批准号:
    26242074
  • 财政年份:
    2014
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Development of short-step synthesis of probe molecules for accelerating target identification
开发探针分子的短步合成以加速目标识别
  • 批准号:
    25560402
  • 财政年份:
    2013
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Establishment of in vivo screening system using Medaka fish toward to the drug discovery
建立利用青鳉鱼进行药物发现的体内筛选系统
  • 批准号:
    22659002
  • 财政年份:
    2010
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Investigation of benthonic marine organisms in Indonesia searching for new medicinal seeds.
对印度尼西亚底栖海洋生物进行调查,寻找新的药用种子。
  • 批准号:
    21406002
  • 财政年份:
    2009
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Search for Bioactive Natural Products for Molecular Target Chemotherapy of Cancer
寻找用于癌症分子靶向化疗的生物活性天然产物
  • 批准号:
    18201042
  • 财政年份:
    2006
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Investigation of Indonesian Marine Organisms as Medicinal Resources
印度尼西亚海洋生物作为药用资源的调查
  • 批准号:
    15406005
  • 财政年份:
    2003
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Search for inhibitors of cell cycle and development for natural molecular probe
细胞周期抑制剂的寻找及天然分子探针的开发
  • 批准号:
    15310148
  • 财政年份:
    2003
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Search for Indonesian Marine Life as Medicinal Resource (2)
寻找印度尼西亚海洋生物作为药用资源 (2)
  • 批准号:
    11691208
  • 财政年份:
    1999
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Search for New Anti-tumor Lead Compounds from Marine Organisms
从海洋生物中寻找新的抗肿瘤先导化合物
  • 批准号:
    10557233
  • 财政年份:
    1998
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Search for Indonesian Marine Life as Medicinal Resource
寻找印度尼西亚海洋生物作为药用资源
  • 批准号:
    09041184
  • 财政年份:
    1997
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for international Scientific Research

相似国自然基金

P-glycoprotein与Rack1和Src相互作用并促进耐药乳腺癌细胞侵袭转移的分子机制研究
  • 批准号:
    81472474
  • 批准年份:
    2014
  • 资助金额:
    85.0 万元
  • 项目类别:
    面上项目

相似海外基金

Inhibition or evasion of P-glycoprotein-mediated drug transport
抑制或逃避 P-糖蛋白介导的药物转运
  • 批准号:
    10568723
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Physiological function of P-glycoprotein in sanctuary tissue barriers in teleosts
P-糖蛋白在硬骨鱼保护区组织屏障中的生理功能
  • 批准号:
    RGPIN-2020-04905
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Discovery Grants Program - Individual
Studies of P-glycoprotein Drug Interactions - Administrative Supplement for Undergraduate Summer Research
P-糖蛋白药物相互作用的研究 - 本科生暑期研究行政补充
  • 批准号:
    10810072
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Bacterial targeting of the P-glycoprotein/endocannabinoid axis for reducing intestinal inflammation in ulcerative colitis
细菌靶向 P-糖蛋白/内源性大麻素轴以减少溃疡性结肠炎的肠道炎症
  • 批准号:
    10537517
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Studies of P-glycoprotein drug interactions
P-糖蛋白药物相互作用的研究
  • 批准号:
    10661486
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Drug, Nucleotide, and Lipid Interactions with P-glycoprotein
药物、核苷酸和脂质与 P-糖蛋白的相互作用
  • 批准号:
    10672242
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Mechanisms of suicide attempts by loss of P-glycoprotein function in the blood-brain barrier
血脑屏障中 P-糖蛋白功能丧失导致自杀未遂的机制
  • 批准号:
    22K06774
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies of P-glycoprotein drug interactions
P-糖蛋白药物相互作用的研究
  • 批准号:
    10366914
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Studies of P-glycoprotein Drug Interactions - Administrative Supplement for Equipment Purchase
P-糖蛋白药物相互作用研究-设备采购行政补充
  • 批准号:
    10795338
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Physiological function of P-glycoprotein in sanctuary tissue barriers in teleosts
P-糖蛋白在硬骨鱼保护区组织屏障中的生理功能
  • 批准号:
    RGPIN-2020-04905
  • 财政年份:
    2021
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了